| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
European Institute for Peptide Research (IFRMP 23), Laboratory of Cellular and Molecular Neuroendocrinology, Institut National de la Santé et de la Recherche Médicale (INSERM U413), Centre National de la Recherche Scientifique (UA CNRS), University of Rouen, 76821 Mont-Saint-Aignan, France
Address all correspondence and requests for reprints to: Dr. H. Vaudry, European Institute for Peptide Research (IFRMP 23), Laboratory of Cellular and Molecular Neuroendocrinology, INSERM U-413, UA CNRS, University of Rouen, 76821 Mont-Saint-Aignan, France. E-mail: hubert.vaudry{at}univ-rouen.fr
Chromogranin A (CgA) is a neuroendocrine secretory protein that is widely used as a marker for endocrine neoplasms but whose function is not completely understood. In mammals, it is thought that CgA is a precursor for biologically active peptides. Here, we describe the cloning of a complementary DNA encoding CgA from a nonmammalian vertebrate, the frog Rana ridibunda. Sequence analysis revealed that frog CgA exhibits only 4044% amino acid sequence similarity with its mammalian homologues. The amino acid identity is confined to three regions (7080% identity) of the protein that are flanked by conserved pairs of basic amino acid residues, suggesting that proteolytic processing at these cleavage sites may give rise to three biologically active peptides whose sequences have been highly preserved during evolution. Tissue distribution analysis by Northern blot and in situ hybridization revealed the widespread expression of frog CgA messenger RNA in the brain and in endocrine tissues, the highest concentration occurring in the distal lobe of the pituitary. Adaptation of frog skin color to a dark background caused a concomitant increase in CgA and POMC messenger RNA levels in the intermediate lobe of the pituitary. Taken together, these data indicate that CgA may function as a precursor to three highly conserved peptides that may exert regulatory functions in the neuroendocrine system.
This article has been cited by other articles:
![]() |
M. Montero-Hadjadje, S. Elias, L. Chevalier, M. Benard, Y. Tanguy, V. Turquier, L. Galas, L. Yon, M. M. Malagon, A. Driouich, et al. Chromogranin A Promotes Peptide Hormone Sorting to Mobile Granules in Constitutively and Regulated Secreting Cells: ROLE OF CONSERVED N- AND C-TERMINAL PEPTIDES J. Biol. Chem., May 1, 2009; 284(18): 12420 - 12431. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Peinado, R. Vazquez-Martinez, D. Cruz-Garcia, A. Ruiz-Navarro, Y. Anouar, M. C. Tonon, H. Vaudry, F. Gracia-Navarro, J. P. Castano, and M. M. Malagon Differential Expression and Processing of Chromogranin A and Secretogranin II in Relation to the Secretory Status of Endocrine Cells Endocrinology, March 1, 2006; 147(3): 1408 - 1418. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Montero-Hadjadje, G. Pelletier, L. Yon, S. Li, J. Guillemot, R. Magoul, Y. Tillet, H. Vaudry, and Y. Anouar Biochemical Characterization and Immunocytochemical Localization of EM66, a Novel Peptide Derived from Secretogranin II, in the Rat Pituitary and Adrenal Glands J. Histochem. Cytochem., August 1, 2003; 51(8): 1083 - 1095. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Colombo, R. Longhi, C. Marinzi, F. Magni, A. Cattaneo, S. H. Yoo, F. Curnis, and A. Corti Cleavage of Chromogranin A N-terminal Domain by Plasmin Provides a New Mechanism for Regulating Cell Adhesion J. Biol. Chem., November 22, 2002; 277(48): 45911 - 45919. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tostivint, D. Vieau, N. Chartrel, I. Boutelet, L. Galas, A. Fournier, I. Lihrmann, and H. Vaudry Expression and Processing of the [Pro2,Met13]Somatostatin-14 Precursor in the Intermediate Lobe of the Frog Pituitary Endocrinology, September 1, 2002; 143(9): 3472 - 3481. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Turquier, L. Yon, L. Grumolato, D. Alexandre, A. Fournier, H. Vaudry, and Y. Anouar Pituitary Adenylate Cyclase-Activating Polypeptide Stimulates Secretoneurin Release and Secretogranin II Gene Transcription in Bovine Adrenochromaffin Cells through Multiple Signaling Pathways and Increased Binding of Pre-Existing Activator Protein-1-Like Transcription Factors Mol. Pharmacol., July 1, 2001; 60(1): 42 - 52. [Abstract] [Full Text] |
||||
![]() |
K. Lugardon, R. Raffner, Y. Goumon, A. Corti, A. Delmas, P. Bulet, D. Aunis, and M.-H. Metz-Boutigue Antibacterial and Antifungal Activities of Vasostatin-1, the N-terminal Fragment of Chromogranin A J. Biol. Chem., April 6, 2000; 275(15): 10745 - 10753. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Cowley, Y. R. Moore, D. S. Darling, P. B. M. Joyce, and S.-U. Gorr N- and C-terminal Domains Direct Cell Type-specific Sorting of Chromogranin A to Secretory Granules J. Biol. Chem., March 10, 2000; 275(11): 7743 - 7748. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ratti, F. Curnis, R. Longhi, B. Colombo, A. Gasparri, F. Magni, E. Manera, M.-H. Metz-Boutigue, and A. Corti Structure-Activity Relationships of Chromogranin A in Cell Adhesion. IDENTIFICATION OF AN ADHESION SITE FOR FIBROBLASTS AND SMOOTH MUSCLE CELLS J. Biol. Chem., September 15, 2000; 275(38): 29257 - 29263. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Lugardon, S. Chasserot-Golaz, A.-E. Kieffer, R. Maget-Dana, G. Nullans, B. Kieffer, D. Aunis, and M.-H. Metz-Boutigue Structural and Biological Characterization of Chromofungin, the Antifungal Chromogranin A-(47-66)-derived Peptide J. Biol. Chem., September 14, 2001; 276(38): 35875 - 35882. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |